More Drug Makers Tagged as Valsartan Recall Grows
More than 20 European countries, Canada, and the United States have recalled valsartan medications in recent weeks after NDMA was discovered in the drugs’ ingredients manufactured by Zhejiang Huahai Pharmaceuticals of Linhai, China. (Source: WebMD Health)
Source: WebMD Health - August 13, 2018 Category: Consumer Health News Source Type: news

India ’s Hetero pulls heart drug from U.S. amid cancer risk probes
A unit of India ’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug. (Source: Reuters: Health)
Source: Reuters: Health - August 11, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Tainted Valsartan Recall Expands as More Drug Makers Implicated Tainted Valsartan Recall Expands as More Drug Makers Implicated
News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

Skeptical Cardiologist: Where Are My Generic Meds Made?
(MedPage Today) -- Valsartan recall prompts a look by Anthony Pearson, MD (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 10, 2018 Category: American Health Source Type: news

Valsartan Recall Expanded, FDA Investigating Products from Outside China
(MedPage Today) -- Other ARB manufacturers subject to FDA investigation (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 10, 2018 Category: Cardiology Source Type: news

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)
As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level. This recall of multiple batches of Valsartan Tablets was prompted due to the detection of trace amounts of N-Nitrosodimethylamine (NDMA), a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer). (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 9, 2018 Category: Food Science Source Type: news

FDA Expands Recall Of Common Blood Pressure Drug Over Cancer Concern
(CNN) — The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure. The FDA initially announced a valsartan recall in July after lab tests discovered that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had previously been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were impacted. N-nitrosodimethylamine or NDMA, the i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 8, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News Local TV Recall Valsartan Source Type: news

FDA expands recall of blood pressure drug valsartan due to cancer concern
The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure. (Source: CNN.com - Health)
Source: CNN.com - Health - August 8, 2018 Category: Consumer Health News Source Type: news

FDA expands recall of common heart medication Valsartan
A common heart medication may contain a cancer-causing chemical, the FDA said. (Source: ABC News: Health)
Source: ABC News: Health - August 7, 2018 Category: Consumer Health News Tags: Health Source Type: news

Valsartan Tablets (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 2, 2018 Category: Drugs & Pharmacology Source Type: news

Sacubitril/valsartan cost  effective for heart failure in Germany
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2018 Category: Drugs & Pharmacology Source Type: news

Blood pressure pills recalled worldwide amid cancer chemical scare
Common blood pressure drug valsartan made by Chinese firm Zhejiang Huahai has been banned and recalled by Chinese authorities after it was found to contain a cancer-causing chemical. (Source: the Mail online | Health)
Source: the Mail online | Health - July 31, 2018 Category: Consumer Health News Source Type: news

Net Widens for Companies Over Tainted Valsartan Recalls Net Widens for Companies Over Tainted Valsartan Recalls
The FDA reports that several additional companies that repackage drug products are also recalling products containing the heart drug valsartan, and it says more recalls are likely.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Statin'Shove' vs'Nudge'; ESC Pirates; Expanded Valsartan Recall
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 30, 2018 Category: Cardiology Source Type: news

China orders medical institutions to stop using recalled Huahai-made drug
China's health regulator on Monday said all domestic medical institutions must cooperate with authorities and not use the valsartan blood and heart drug made by Zhejiang Huahai Pharmaceutical Co Ltd that could pose cancer risks. (Source: Reuters: Health)
Source: Reuters: Health - July 30, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

China says its medical institutions must not use recalled Huahai-made drug
China's health regulator said on Monday all domestic medical institutions must cooperate with authorities and not use the valsartan blood and heart drug made by Zhejiang Huahai Pharmaceutical that could pose cancer risks. (Source: Reuters: Health)
Source: Reuters: Health - July 30, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

China orders medical institutions not to use recalled valsartan drug
China's health regulator has called on all medical institutions to cooperate with authorities and not use the valsartan blood and heart drug that is said to pose cancer risks. (Source: Reuters: Health)
Source: Reuters: Health - July 30, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Heart Failure Guidelines: Introduction to the New Agents Heart Failure Guidelines: Introduction to the New Agents
Review updated guidelines for the management of heart failure that have been revised to include the two novel pharmacologic agents sacubitril/valsartan and ivabradine.U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

FDA Issues Recall Alert for Some Drugs Containing Valsartan
The FDA recently issued multiple safety alerts announcing voluntary recalls of drug products containing the active ingredient valsartan from a specific supply source. (Source: AAFP News)
Source: AAFP News - July 25, 2018 Category: Primary Care Source Type: news

Affected by the Valsartan Heart Drug Recall? Here's What to Do
Title: Affected by the Valsartan Heart Drug Recall? Here's What to DoCategory: Health NewsCreated: 7/19/2018 12:00:00 AMLast Editorial Review: 7/20/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 20, 2018 Category: Cardiology Source Type: news

India launches probe as Chinese company recalls BP drug
Valsartan is used to treat patients with high blood pressure in order to reduce complications such as heart attack and stroke. Both the importer and the manufacturer, Zhejiang Huahai Pharmaceuticals, will be issued notice soon. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2018 Category: Pharmaceuticals Source Type: news

FDA Recalls Drugs Containing Active Ingredient Valsartan
THURSDAY, July 19, 2018 -- Several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure, are being recalled due to an impurity, N-nitrosodimethylamine, that has been found in the recalled... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 19, 2018 Category: Pharmaceuticals Source Type: news

Affected by the Valsartan Heart Drug Recall? Here's What to Do
THURSDAY, July 19, 2018 -- After the U.S. Food and Drug Administration announced last week that certain brands of blood pressure medicines contained a carcinogen and were being recalled, many patients may wonder what's next for their cardiovascular... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 19, 2018 Category: General Medicine Source Type: news

Chinese pharma firm recalls heart drug in U.S. after possible impurity
The Chinese bulk manufacturer of the common blood and heart drug valsartan said it was recalling the product from consumers in the United States and would halt supplies to the country, after an impurity linked to cancer had been detected. (Source: Reuters: Health)
Source: Reuters: Health - July 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Valsartan drug recall: 4 things patients should know
Several common drugs that contain valsartan, used to treat high blood pressure and heart failure, were recalled in the United States on Friday due to an "impurity" in the drug that poses a potential cancer risk. (Source: CNN.com - Health)
Source: CNN.com - Health - July 19, 2018 Category: Consumer Health News Source Type: news

US regulators recall blood pressure drug over cancer fears
The UK recalled valsartan two weeks ago, America has now followed suit. The drug has been widely prescribed globally for 15 years. But new evidence suggests that batches have been contaminated. (Source: the Mail online | Health)
Source: the Mail online | Health - July 18, 2018 Category: Consumer Health News Source Type: news

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets
Teva Pharmaceuticals USA today confirmed a voluntary recall to the consumer / user level of 29 lots of single and 51 lots of combination valsartan medicines distributed under the Actavis label in the U.S. due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceutical. The impurity detected in the API is N- nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International ...
Source: Food and Drug Administration - July 17, 2018 Category: Food Science Source Type: news

3 Companies Recall Blood Pressure Medications Over Cancer Fears
Some drugs used to control high blood pressure and prevent heart failure were voluntarily recalled this past week due to an impurity that could possibly lead to cancer, the U.S. Food and Drug Administration said. These products — with the active ingredient valsartan, a generic drug used to treat high blood pressure — may contain N-nitrosodimethylamine (NDMA), a possible human carcinogen. The FDA asked three companies, Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals Industries Ltd., to recall their valsartan products. Solco and Teva were also asked to recall their drugs containing valsartan/hydr...
Source: TIME: Health - July 17, 2018 Category: Consumer Health News Authors: Jennifer Calfas Tags: Uncategorized medicine onetime Source Type: news

Blood Pressure Medicine Is Recalled
The F.D.A. announced that batches of a widely used generic drug, valsartan, made in China, might be tainted with a probable cancer-causing ingredient. (Source: NYT Health)
Source: NYT Health - July 16, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN Tags: Drugs (Pharmaceuticals) Recalls and Bans of Products Food and Drug Administration China Blood Pressure valsartan Source Type: news

Major Pharmaceuticals Issues Voluntary Nationwide Recall of Valsartan Due to The Potential Presence of a Probable Carcinogen (NDMA)
As a precautionary measure, the distribution firm, Major Pharmaceuticals, is issuing a nationwide voluntary recall of all lots within expiry of Valsartan which were supplied by Teva Pharmaceuticals and labeled as Major Pharmaceuticals. (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 16, 2018 Category: Food Science Source Type: news

Valsartan Recall; Wearable Salt Tracker; Killer Plastic Surgery Clots
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 16, 2018 Category: Cardiology Source Type: news

FDA Recalls Some Valsartan Drugs Due to Impurity
The FDA is investigating how much NDMA is in the recalled products and is trying to find out the possible effects on patients who have been taking them. (Source: WebMD Health)
Source: WebMD Health - July 16, 2018 Category: Consumer Health News Source Type: news

FDA recalls heart failure, blood pressure drugs due to cancerous contaminant
The FDA announced last week a voluntary recall of several high blood pressure and heart failure medications containing valsartan due to a cancerous impurity. Some valsartan drugs were found to contain N-nitrosodimethylamine (NDMA), a compound that is classified as a probable human carcinogen. Get the full story at our sister site, Drug Delivery Business News. The post FDA recalls heart failure, blood pressure drugs due to cancerous contaminant appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Food & Drug Administration (FDA) Pharmaceuticals Recalls Regulatory/Compliance Wall Street Beat Teva Pharmaceuticals Source Type: news

FDA Recalls Some Valsartan Drugs Due to Impurity
Title: FDA Recalls Some Valsartan Drugs Due to ImpurityCategory: Health NewsCreated: 7/16/2018 12:00:00 AMLast Editorial Review: 7/16/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 16, 2018 Category: Cardiology Source Type: news

FDA Recalls Some Valsartan Drugs Due to Impurity
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 16, 2018 Category: General Medicine Source Type: news

FDA Recalls Common Heart Drug For Potential Cancer Risk
(CNN) — The recall of a common drug used to control blood pressure and help prevent heart failure was announced by the US Food and Drug Administration on Friday, a week after 22 other countries recalled it because the drug contains a chemical that poses a potential cancer risk. Valsartan is off patent and is used as a component of other generic medicines, but not all medicines containing the ingredient are involved, according to the FDA. The US recall includes the the versions of valsartan that are made by Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals Industries Ltd. as well as valsartan/hydrochlor...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 16, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Valsartan Source Type: news

FDA Recalls Some Valsartan Medicines Due to Impurity FDA Recalls Some Valsartan Medicines Due to Impurity
Three companies are recalling several drug products containing valsartan due to the presence of N-nitrosodimethylamine, which is classified as a probable human carcinogen.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 14, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products
Prinston Pharmaceutical Inc. dba Solco Healthcare LLC. is recalling all lots of Valsartan Tablets, 40 mg, 80mg, 160mg, and 320mg; and Valsartan-Hydrochlorothiazide Tablets, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg, and 320mg/25mg to the retail level. This product recall is due to the detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA), made by the manufacturer – Zhejiang Huahai Pharmaceutical Co. Ltd. -- that is used in the manufacture of the subject product lots. This impurity has been classified as a probable human carcinogen as per International Agency for Research on Ca...
Source: Food and Drug Administration - July 13, 2018 Category: Food Science Source Type: news

FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity
FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 13, 2018 Category: American Health Source Type: news

FDA Announces Voluntary Recall of Several Medicines Containing Valsartan Following Detection of an Impurity
July 13, 2018 -- The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2018 Category: Pharmaceuticals Source Type: news

Class 1 Medicines Recall: Action Now including out of hours Pharmacy Level Recall: Superseded drug alert - Valsartan/Hydrochlorothiazide 160/12.5mg Film-Coated Tablets
The Medicines& Healthcare products Regulatory Agency (MHRA) issued a Class 1 Medicines Recall (Drug Alert EL (18)A/11) on 5th July 2018. Pharmacies in the UK were asked to recall all batches of v (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 11, 2018 Category: Drugs & Pharmacology Source Type: news

Some heart, high blood pressure drugs containing valsartan recalled due to cancer risk
Several heart and high blood pressure drugs that contain valsartan are being recalled because of a substance that can cause cancer. (Source: CBC | Health)
Source: CBC | Health - July 10, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Morning Break: Burnout Errors; Trump Bashes Pfizer; Valsartan Recall
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 10, 2018 Category: American Health Source Type: news

Common Heart Drug Recalled In 22 Countries For Possible Cancer Link
(CNN) — A common drug used to control blood pressure and help prevent heart failure is being recalled in 22 countries because it contains a chemical that poses a potential cancer risk. Valsartan is off-patent and is used as a component of other generic medicines. Novartis, the company that originally developed the drug, said Sandoz valsartan and valsartan/HCT film-coated tablets are being recalled since they “do not meet our high quality standards.” Pharmacies in the UK are advised to recall valsartan batches containing medicines made by Dexcel Pharma Ltd and Accord Healthcare. The recall involves about 2...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 6, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Valsartan Source Type: news

Common heart drug is recalled in 22 countries for possible cancer link
The heart medicine valsartan is being recalled in 22 countries due to a potential cancer risk. (Source: CNN.com - Health)
Source: CNN.com - Health - July 6, 2018 Category: Consumer Health News Source Type: news

EU Officials Recall Some Valsartan Medicines Due to Impurity EU Officials Recall Some Valsartan Medicines Due to Impurity
The European Medicines Agency is reviewing the medicines after an impurity, thought to be a probable human carcinogen, was detected in the active ingredient supplied by a Chinese company.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

Common heart drug recalled amid fears it could cause cancer
The Medicines and  Healthcare products Regulatory Agency revealed the fault stems from a Chinese facility making the active substance valsartan. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news

Class 1 Medicines Recall: Action Now including out of hours Pharmacy Level Recall: Valsartan capsules and tablets
The Medicines& Healthcare products Regulatory Agency (MHRA) hasissued a Class 1 Medicines Recall. Pharmacies in the UK are being advised to recall all batches of valsartan containing medicines ma (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 5, 2018 Category: Drugs & Pharmacology Source Type: news

Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto ®
Novartis announced today new real world evidence from the CHAMP-HF registry comparing Entresto® (sacubitril/valsartan) patients to patients not taking Entresto.[1] This pre-specified analysis of an interim data cut from the CHAMP-HF registry showed that chronic heart failure (HF) patients with reduced ejection fraction (HFrEF) taking Entresto reported early, statistically significant improvement in health status, as measured by the KCCQ-12 overall summary score (KCCQ-OS). (Source: World Pharma News)
Source: World Pharma News - May 28, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Research Scandal Involving Popular Heart Drug Engulfs Three More Papers
The scientists involved have hired lawyers to fight the conclusions of a recent investigation into some studies of Diovan in Japan. (Source: The Scientist)
Source: The Scientist - May 4, 2018 Category: Science Tags: Daily News,News & Opinion,The Scientist Source Type: news